Related Experiment Videos
Active lupus in a patient receiving long-term hemodialysis
Southern Medical Journal
|April 1, 1986
Summary
Systemic lupus erythematosus (SLE) can become aggressive during hemodialysis. This case highlights the need for careful monitoring and immunosuppressive therapy in SLE patients undergoing renal replacement therapy.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Hemodialysis is a renal replacement therapy for end-stage kidney disease.
Observation:
- A patient with disseminated SLE experienced disease exacerbation after 8-10 months of hemodialysis.
- The SLE activity became aggressive and life-threatening.
Findings:
- Hemodialysis may potentially trigger or worsen SLE activity in some patients.
- High-dose immunosuppressive therapy was required to manage the aggressive SLE.
Implications:
- This case underscores the importance of vigilant monitoring for SLE flares in patients on hemodialysis.
- Further research is needed to understand the interaction between hemodialysis and SLE pathogenesis.
- Consideration of alternative renal replacement therapies or intensified immunosuppression may be warranted for select SLE patients.